Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients

Kahraman S., Yilmaz R., Kirkpantur A., Genctoy G., Arici M., Altun B., ...More

NEPHROLOGY, vol.10, no.3, pp.264-269, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 3
  • Publication Date: 2005
  • Doi Number: 10.1111/j.1440-1797.2005.00405.x
  • Journal Name: NEPHROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.264-269
  • Hacettepe University Affiliated: No


Background: Increased levels of soluble adhesion molecules have been reported in haemodialysis (HD) patients. Recent studies have shown that recombinant human erythropoietin (rHuEPO) elicits proliferation and migration of endothelial cells and modifies endothelial function. The present study was design to explore the effects of rHuEPO on serum levels of soluble adhesion molecules in HD patients.